137 related articles for article (PubMed ID: 31092692)
1. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.
Ko SY; Akahata W; Yang ES; Kong WP; Burke CW; Honnold SP; Nichols DK; Huang YS; Schieber GL; Carlton K; DaSilva L; Traina-Dorge V; Vanlandingham DL; Tsybovsky Y; Stephens T; Baxa U; Higgs S; Roy CJ; Glass PJ; Mascola JR; Nabel GJ; Rao SS
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092692
[TBL] [Abstract][Full Text] [Related]
2. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
3. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
[TBL] [Abstract][Full Text] [Related]
4. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
[TBL] [Abstract][Full Text] [Related]
6. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
7. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model.
Burke CW; Erwin-Cohen RA; Goodson AI; Wilhelmsen C; Edmundson JA; White CE; Glass PJ
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891482
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
[TBL] [Abstract][Full Text] [Related]
11. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses.
Pedersen CE
J Clin Microbiol; 1976 Feb; 3(2):113-8. PubMed ID: 942635
[TBL] [Abstract][Full Text] [Related]
12. Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate.
Toprani VM; Cheng Y; Wahome N; Khasa H; Kueltzo LA; Schwartz RM; Middaugh CR; Joshi SB; Volkin DB
J Pharm Sci; 2018 Oct; 107(10):2544-2558. PubMed ID: 29883665
[TBL] [Abstract][Full Text] [Related]
13. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
[TBL] [Abstract][Full Text] [Related]
14. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
[TBL] [Abstract][Full Text] [Related]
15. Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.
Phelps AL; O'Brien LM; Ulaeto DO; Holtsberg FW; Liao GC; Douglas R; Aman MJ; Glass PJ; Moyer CL; Ennis J; Zeitlin L; Nagata LP; Hu WG
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835037
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A
Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure.
Burke CW; Froude JW; Rossi F; White CE; Moyer CL; Ennis J; Pitt ML; Streatfield S; Jones RM; Musiychuk K; Kervinen J; Zeitlin L; Yusibov V; Glass PJ
PLoS Pathog; 2019 Dec; 15(12):e1008157. PubMed ID: 31790515
[TBL] [Abstract][Full Text] [Related]
18. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
[TBL] [Abstract][Full Text] [Related]
19. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
20. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
